Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

Haematologica. 2024 Aug 1;109(8):2716-2720. doi: 10.3324/haematol.2024.285010.
No abstract available

Publication types

  • Letter

MeSH terms

  • Female
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / methods
  • Lymphoma, Large B-Cell, Diffuse* / immunology
  • Lymphoma, Large B-Cell, Diffuse* / therapy
  • Male
  • Receptors, Chimeric Antigen* / immunology
  • Treatment Outcome

Substances

  • Receptors, Chimeric Antigen